$669 Million is the total value of MFN Partners Management, LP's 14 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 17.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | Buy | ALLERGAN PLC | $235,623,000 | +56.3% | 1,400,101 | +55.5% | 35.22% | +47.2% |
| FOXA | FOX CORP | $74,717,000 | -13.9% | 2,369,331 | 0.0% | 11.17% | -18.9% | |
| LBTYK | Buy | LIBERTY GLOBAL PLC | $71,370,000 | +330.0% | 3,000,000 | +379.6% | 10.67% | +304.9% |
| LNG | Buy | CHENIERE ENERGY INC | $66,213,000 | +29.0% | 1,050,000 | +40.0% | 9.90% | +21.4% |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $55,283,000 | +2.3% | 6,439,541 | +30.4% | 8.26% | -3.7% |
| XPO | Sell | XPO LOGISTICS INC | $50,099,000 | -5.2% | 700,000 | -23.4% | 7.49% | -10.7% |
| PXD | Buy | PIONEER NAT RES CO | $33,140,000 | +7.7% | 263,500 | +31.8% | 4.95% | +1.4% |
| PCG | PG&E CORP | $28,000,000 | -56.4% | 2,800,000 | 0.0% | 4.19% | -58.9% | |
| FG | Sell | FGL HLDGS | $23,112,000 | -8.3% | 2,896,186 | -3.5% | 3.46% | -13.6% |
| CYCN | CYCLERION THERAPEUTICS INC | $18,033,000 | +5.9% | 1,487,874 | 0.0% | 2.70% | -0.3% | |
| GTTN | Sell | GTT COMMUNICATIONS INC | $9,242,000 | -58.0% | 981,143 | -21.5% | 1.38% | -60.4% |
| EOLS | EVOLUS INC | $1,874,000 | +6.8% | 120,000 | 0.0% | 0.28% | +0.7% | |
| ACRS | ACLARIS THERAPEUTICS INC | $1,620,000 | -50.7% | 1,500,000 | 0.0% | 0.24% | -53.6% | |
| RVNC | REVANCE THERAPEUTICS INC | $598,000 | +0.2% | 46,000 | 0.0% | 0.09% | -6.3% | |
| NAVI | Exit | NAVIENT CORPORATION | $0 | – | -244,300 | -100.0% | -0.53% | – |
| TAK | Exit | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $0 | – | -785,000 | -100.0% | -2.21% | – |
| GS | Exit | GOLDMAN SACHS GROUP INC | $0 | – | -173,811 | -100.0% | -5.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XPO LOGISTICS INC | 20 | Q3 2023 | 31.8% |
| LIBERTY GLOBAL PLC- C | 18 | Q3 2023 | 18.6% |
| CYCLERION THERAPEUTICS INC | 16 | Q1 2023 | 2.7% |
| HCA HEALTHCARE INC | 15 | Q3 2023 | 10.9% |
| CHENIERE ENERGY INC | 13 | Q4 2021 | 19.2% |
| OCCIDENTAL PETROLEUM CORP | 13 | Q3 2023 | 10.5% |
| PENNYMAC FINL SVCS INC NEW | 11 | Q3 2023 | 12.2% |
| ALPHABET INC-CL A | 9 | Q2 2023 | 12.9% |
| LITHIA MTRS INC | 8 | Q3 2023 | 16.0% |
| META PLATFORMS INC | 7 | Q4 2021 | 14.1% |
View MFN Partners Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Foley Trasimene Acquisition Corp. | March 15, 2021 | 5,000,000 | 4.8% |
| Cyclerion Therapeutics, Inc. | February 12, 2021 | 2,427,677 | 7.2% |
| Foley Trasimene Acquisition Corp. | February 12, 2021 | 14,000,000 | 13.5% |
| Foley Trasimene Acquisition IISold out | February 12, 2021 | 0 | 0.0% |
| Aclaris Therapeutics, Inc. | July 22, 2020 | 1,895,677 | 4.5% |
View MFN Partners Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-26 |
| 4 | 2024-04-24 |
| 4 | 2024-04-19 |
| 4 | 2024-04-17 |
| 13F-HR | 2024-02-13 |
| 4 | 2024-02-12 |
| 4 | 2024-02-06 |
| 4 | 2023-11-24 |
| 4 | 2023-11-20 |
| 4 | 2023-11-15 |
View MFN Partners Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.